ロード中...
Efficacy and safety of sacubitril‐valsartan in heart failure: a meta‐analysis of randomized controlled trials
AIMS: Sacubitril‐valsartan has been shown to have superior effects over angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in patients with heart failure (HF) and hypertension. The efficacy and safety of sacubitril‐valsartan in patients with HF are controversial. We performed...
保存先:
| 出版年: | ESC Heart Fail |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754944/ https://ncbi.nlm.nih.gov/pubmed/32977362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12974 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|